|Bid||116.35 x 800|
|Ask||116.45 x 900|
|Day's range||116.12 - 119.15|
|52-week range||79.11 - 119.15|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||31.36|
|Earnings date||28 Oct 2021 - 01 Nov 2021|
|Forward dividend & yield||5.20 (4.47%)|
|Ex-dividend date||14 Jul 2021|
|1y target est||124.08|
You might think that any stock handpicked by Warren Buffett and his top investment managers would be held in high regard by most investors. Several stocks in Berkshire Hathaway's (NYSE: BRK.A) (NYSE: BRK.B) portfolio are either beaten down, have bargain valuations, or both. Here are three underrated Buffett stocks that are smart buys right now.
ABBV earnings call for the period ending June 30, 2021.
AbbVie (ABBV) matches second-quarter 2021 earnings estimates while beating the same for sales. Sales of new immunology drugs, Skyrizi and Rinvoq, reach $1 billion.